MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z
  • Vaccination from Covid-19 in people with Parkinson`s disease

    J. Salimjonov, N. Rashidova, K. Khalimova, R. Matmurodov (Tashkent, Uzbekistan)

  • Vagus nerve degeneration in Parkinson’s disease: correlation with autonomic symptoms and pupillography

    M. Batchakaschvili, M. Löhle, HR. Kleinlein, W. Hermann, H. Walter, A. Storch, U. Walter (Rostock, Germany)

  • Validating A New Writer’s Cramp Impairment Scale

    E. Shamim, G. Stebbins, B. Hodsdon, K. Alter, B. Karp, O. Ahmad, P. Srivanitchapoom, K. Mente, C. Toro, S. Meunier, M. Hallett (Rockville, USA)

  • Validating wearable sensors as an assessment tool for Parkinson’s Disease

    K. Silis, N. Kieran, N. Shawki, S. Madarshahian, M. Serruya, T. Liang (Philadelphia, USA)

  • Validation and psychometric properties of the Thai version of the hemifacial spasm grading questionnaire (HFS score) for physician-assessed clinical involvement and patient-reported health-related quality of life: a prospective observational study

    ���N. Likhitwitayawuid, Y. Pitakpatapee, W. Saengphatarachai, P. Srivanitchapoom (Bangkok, Thailand)

  • Validation and replication of Parkinson disease behavioral subtypes

    C. Lessov-Schlaggar, P. Myers, J. Jackson, B. Maiti, P. Kotzbauer, J. Perlmutter, M. Campbell (St. Louis, USA)

  • Validation of a Remote Patient Monitoring System for Parkinson Symptom Severity

    D. Fox, C. Weaver, L. Mischley (Seattle, USA)

  • VALIdation of models for assessing eligibility for referral for Device-Aided Treatment in Parkinson’s disease (VALIDATE)

    H. Moes, E. Buskens, A. Portman, B. van Harten, M. van Kesteren, T. Mondria, L. Teune, E. van Wensen, M. van Onna, M. Schilperoord, A. Wertenbroek, M. Tjepkema-Cloostermans, L. Dorresteijn, T. van Laar (Groningen, Netherlands)

  • Validation of the EQ-5D-3L in Spinocerebellar Ataxia (SCA)

    M. Buchholz, N. Weber, A. Rädke, J. Faber, T. Schmitz-Hübsch, H. Jacobi, F. Xie, T. Klockgether, B. Michalowsky (Greifswald, Germany)

  • Validation of the Japanese version of the King’s Parkinson’s Disease Pain Scale and the King’s Parkinson’s Disease Pain Questionnaire

    K. Kurihara, S. Zfujioka, T. Mishima, Y. Tsuboi (Fukuoka, Japan)

  • Validation of the Patient Reported Outcomes in Parkinson’s Disease scale in outpatients

    D. von Below, S. Wallerstedt, F. Bergquist (Gothenburg, Sweden)

  • Validity and reliability of muscle peak power testing in persons with Parkinson’s disease

    F. Jensen, M. Langeskov-Christensen, L. Hvid, U. Dalgas (Aarhus, Denmark)

  • Validity and Reliability of the Turkish Version of the Radboud Oral Motor Inventory for Parkinson’s Disease (ROMP)

    M. Sapmaz Atalar, G. Genç, D. Selçuk Demi̇relli̇ (Kadıköy, Turkey)

  • Validity and responsiveness of the EQ-5D-3L in Friedreich-Ataxia

    N. Weber, M. Buchholz, A. Rädke, T. Klockgether, B. Michalowsky (Greifswald, Germany)

  • Variant frequencies in dystonia and Parkinson’s disease genes cross phenotypic boundaries

    L. Lange, A. Illarionova, K. Grütz, EJ. Vollstedt, B-H. Laabs, S. Löns, G. Kilic-Berkmen, F. Hinrichs, H. Padlock, L. Screven, T. Bäumer, H. Jinnah, N. Brüggemann, Z-H. Fang, K. Lohmann, C. Klein (Luebeck, Germany)

  • Ventral tegmental deep brain stimulation does not influence risk-taking behaviour in a standard gambling task

    S. Hirschbichler, S. Lagrata, M. Matharu, S. Manohar (St. Pölten, Austria)

  • Verbal Fluency Changes After Unilateral STN Deep Brain Stimulation in Parkinson’s Disease: A Connectomics-Based Approach

    MJ. Kim, I. Zuccaroli, V. Del Bene, S. Brinkerhoff, R. Martin, J. Olson, M. Nelson, C. Gonzalez, V. Kamath, J. Bentley, B. Guthrie, R. Knight, H. Walker, K. Mills (Baltimore, USA)

  • Vertigo: Sway pattern indicating a functional movement disorder

    L. Schappe, N. Rohmann, F. Röll, D. Martens, A. Păniță, J. Stögbauer, G. Wagenpfeil, K. Faßbender, U. Dillmann (Homburg, Germany)

  • Very high frequency of early-onset Parkinson’s disease with homozygous PRKN exon 3 deletion amongst indigenous populations in Sabah, Malaysia

    YW. Tay, JCE. Ooi, SY. Lim, YK. Chia, A. Sukri, TS. Toh, JL. Lim, AH. Tan, A. Ahmad-Annuar (Kuala Lumpur, Malaysia)

  • Video-Based Motor Function Assessment by Professional Raters or by Software in Patients with Parkinson’s Disease

    WX. Wu, GJ. Jing, XX. Xu, LZZ. Li, YF. Yang, GXD. Guo (Shanghai, China)

  • Visual dysfunction of the Superior Colliculus in idiopathic Blepharospasm: a pilot study

    M. Dojat, E. Moro, P. Pelissier, S. Meoni (Grenoble, France)

  • Visual networks connectivity in subjects with Parkinson’s disease and visual disturbances using resting state fMRI

    O. Shoraka, M. Syed, I. Shelley, K. Shivock, TW. Liang, RC. Sergott, I. Fayed, A. Sharan, M. Alizadeh (Philadelphia, USA)

  • Visuo-spatial processing is linked to cortical glutamate dynamics in Parkinson’s disease – a 7 Tesla functional MRS study

    A. Ophey, E. Farrher, N. Pagel, A. Seger, C. Doppler, N. Shah, E. Kalbe, G. Fink, M. Sommerauer (Cologne, Germany)

  • Voice- tremor in a patient with positive VPS 16 nonsense mutation: Expanding the phenotype

    K. Kunj, A. Das, A. Srivastava (New Delhi, India)

  • VPS11 associated movement disorder in a pediatric case

    E. Serdaroglu, A. Serdaroglu (Ankara, Turkey)

Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley